Literature DB >> 9119505

Promoter activities in Vibrio cholerae ctx phi prophage.

R Fando1, J L Pérez, B L Rodriguez, J Campos, A Robert, L García, A Silva, J A Benitez.   

Abstract

Comparison of cholera toxin (CT) production directed by different gene constructs and S1 nuclease mapping revealed the presence of a ctxB-specific promoter within the ctxA coding sequence. Initiation of transcription in this region occurred in wild-type El Tor and classical biotype choleragenic vibrios. We propose that transcription from the ctxB-specific promoter and a stronger ribosomal binding site on the ctxB mRNA synergistically contribute to achieve the correct (5B:1A) subunit stoichiometry. Plasmid pB, a CT promoterless vector expressing only CTB, was used to detect promoter activity by restoration of A-subunit synthesis. Promoter activity expressed in vitro and in vivo was detected upstream of the zonula occludens toxin gene, suggesting that this factor could be produced in vivo to contribute to fluid accumulation. No promoter activity was detected in vitro and in vivo upstream from the accessory cholera enterotoxin gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119505      PMCID: PMC175171          DOI: 10.1128/iai.65.4.1561-1565.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane.

Authors:  S N DE; D N CHATTERJE
Journal:  J Pathol Bacteriol       Date:  1953-10

2.  Lysogenic conversion by a filamentous phage encoding cholera toxin.

Authors:  M K Waldor; J J Mekalanos
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

3.  Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.

Authors:  A Robert; A Silva; J A Benitez; B L Rodriguez; R Fando; J Campos; D K Sengupta; M Boesman-Finkelstein; R A Finkelstein
Journal:  Vaccine       Date:  1996-11       Impact factor: 3.641

4.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

5.  Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli.

Authors:  J Brosius; T J Dull; D D Sleeter; H F Noller
Journal:  J Mol Biol       Date:  1981-05-15       Impact factor: 5.469

Review 6.  Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae.

Authors:  V J DiRita
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

7.  Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12.

Authors:  G D Pearson; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.

Authors:  J A Benítez; A J Silva; B L Rodríguez; R Fando; J Campos; A Robert; H García; L García; J L Pérez; R Oliva; C A Torres; T Ledón
Journal:  Arch Med Res       Date:  1996       Impact factor: 2.235

9.  CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.

Authors:  G D Pearson; A Woods; S L Chiang; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.

Authors:  J Holmgren
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

View more
  5 in total

1.  The Vibrio cholerae vieSAB locus encodes a pathway contributing to cholera toxin production.

Authors:  Anna D Tischler; Sang Ho Lee; Andrew Camilli
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

2.  ToxR-independent expression of cholera toxin from the replicative form of CTXphi.

Authors:  S Lazar; M K Waldor
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  A Vibrio cholerae relaxed (relA) mutant expresses major virulence factors, exhibits biofilm formation and motility, and colonizes the suckling mouse intestine.

Authors:  Anisia J Silva; Jorge A Benitez
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

4.  Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

Authors:  J A Benítez; L García; A Silva; H García; R Fando; B Cedré; A Pérez; J Campos; B L Rodríguez; J L Pérez; T Valmaseda; O Pérez; A Pérez; M Ramírez; T Ledón; M D Jidy; M Lastre; L Bravo; G Sierra
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.

Authors:  M Marinaro; A Di Tommaso; S Uzzau; A Fasano; M T De Magistris
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.